Market Place
Sourcing Support
All News #Library
Biotech
CMS Grants Fresenius Kabi COVID-Specific Codes for Tyenne
09 Apr 2026 //
BUSINESSWIRE
FDA Grants Interchangeable Designation to Kabi’s Biosimilars
29 Oct 2025 //
BUSINESSWIRE
Fresenius Heads EASYGEN Consortium to Decentralize CAR-T Therapy
26 Aug 2025 //
BUSINESSWIRE
Fresenius Adds Denosumab Biosimilars to U.S. Portfolio
01 Jul 2025 //
CONTRACTPHARMA
Fresenius Launches Denosumab Biosimilars in U.S.
01 Jul 2025 //
BUSINESSWIRE
FDA Designates Fresenius Kabi`s Otulfi as Interchangeable
19 May 2025 //
BUSINESSWIRE
BioLife Plasma Services Introduces Fresenius Kabi Nomogram in U.S
05 May 2025 //
BUSINESSWIRE
CMS Grants Fresenius Kabi Permanent Q-Code for Otulfi®
28 Apr 2025 //
BUSINESSWIRE
Fresenius Launches Otulfi (Ustekinumab-aauz) in U.S.
03 Mar 2025 //
BUSINESSWIRE
Fresenius Momentum In (Bio)Pharma, Launches Tyenne® Biosimilar
15 Apr 2024 //
BUSINESSWIRE
Tyenne, Fresenius Kabi’s tocilizumab biosimilar, receives EC approval
20 Sep 2023 //
PRESS RELEASE
Fresenius launches biosimilar version of AbbVie`s Humira at 5% discount
04 Jul 2023 //
REUTERS
Stimufend® (pegfilgrastim-fpgk) Now Available in the United States
16 Feb 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.